AU621368B2 - Pharmaceutical composition containing deoxyribonucleosides and/or deoxyribonucleotides for wound healing - Google Patents

Pharmaceutical composition containing deoxyribonucleosides and/or deoxyribonucleotides for wound healing Download PDF

Info

Publication number
AU621368B2
AU621368B2 AU35713/89A AU3571389A AU621368B2 AU 621368 B2 AU621368 B2 AU 621368B2 AU 35713/89 A AU35713/89 A AU 35713/89A AU 3571389 A AU3571389 A AU 3571389A AU 621368 B2 AU621368 B2 AU 621368B2
Authority
AU
Australia
Prior art keywords
composition
percent
deoxyguanosine
deoxycytidine
matter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU35713/89A
Other languages
English (en)
Other versions
AU3571389A (en
Inventor
Michael Kevin Bamat
Reid Warren Von Borstel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pro Neuron Inc
Original Assignee
Pro Neuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Neuron Inc filed Critical Pro Neuron Inc
Publication of AU3571389A publication Critical patent/AU3571389A/en
Application granted granted Critical
Publication of AU621368B2 publication Critical patent/AU621368B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AU35713/89A 1988-04-25 1989-04-21 Pharmaceutical composition containing deoxyribonucleosides and/or deoxyribonucleotides for wound healing Ceased AU621368B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18603188A 1988-04-25 1988-04-25
US186031 1988-04-25

Publications (2)

Publication Number Publication Date
AU3571389A AU3571389A (en) 1989-11-24
AU621368B2 true AU621368B2 (en) 1992-03-12

Family

ID=22683377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35713/89A Ceased AU621368B2 (en) 1988-04-25 1989-04-21 Pharmaceutical composition containing deoxyribonucleosides and/or deoxyribonucleotides for wound healing

Country Status (13)

Country Link
EP (1) EP0420862B1 (enExample)
JP (1) JPH0635389B2 (enExample)
AU (1) AU621368B2 (enExample)
CA (1) CA1336264C (enExample)
DE (1) DE68910973T2 (enExample)
DK (1) DK176007B1 (enExample)
FI (1) FI905236A7 (enExample)
HK (1) HK1005703A1 (enExample)
IN (1) IN169469B (enExample)
MX (1) MX171542B (enExample)
RU (1) RU2115410C1 (enExample)
WO (1) WO1989010129A1 (enExample)
ZA (1) ZA892928B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034032B2 (ja) 1990-02-13 2000-04-17 グロペップ プロプライエタリー リミテッド 腸疾患用薬剤
CA2444071C (en) * 1991-02-08 2008-10-07 Wellstat Therapeutics Corporation Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
US6342484B1 (en) 1993-06-30 2002-01-29 Board Of Regents, The University Of Texas Systems Method and compositions for promotion of wound treatment
AU7319994A (en) * 1993-06-30 1995-01-24 Board Of Regents, The University Of Texas System Nucleotide preparation and uses thereof in wound healing
TW280772B (enExample) * 1993-08-25 1996-07-11 Otsuka Pharma Factory Inc
US5852000A (en) * 1993-08-25 1998-12-22 Otsuka Pharmaceutical Factory, Inc. Cardiac rehabilitation agent
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
ES2274372T3 (es) * 1999-05-27 2007-05-16 Euro-Celtique S.A. Uso de antisepticos en la fabricacion de un preparado farmaceutico para la prevencion o el tratamiento de inflamaciones en el interior del cuerpo humano.
RU2163485C1 (ru) * 1999-09-02 2001-02-27 Лапина Ольга Фридриховна Способ о.ф. и с.а. лапиных лечения ожогов и других поражений кожи с использованием препарата "дарина"
KR100366439B1 (ko) * 2000-02-21 2003-01-09 주식회사 대웅 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
AU2001286221B2 (en) * 2000-09-13 2006-09-28 Chugai Seiyaku Kabushiki Kaisha Remedies for ischemic diseases
RU2236844C2 (ru) * 2002-04-17 2004-09-27 Ставропольское научно-производственное объединение "Пульс" Противовоспалительное средство наружного применения и способ его получения
JP4790609B2 (ja) * 2003-07-15 2011-10-12 バーイラン ユニバーシティー 創傷治癒のための方法及び薬剤組成物
ES2375565T3 (es) 2003-08-07 2012-03-02 Healor Ltd. Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas.
WO2007026356A2 (en) 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
RU2385744C1 (ru) * 2008-09-02 2010-04-10 Андрей Анатольевич Алексеев Способ лечения глубоких ран
EP2599494A1 (en) 2010-01-11 2013-06-05 Healor Ltd. PKC inhibitors for the treatment of inflammatory disease or disorder
CA2991271C (en) 2015-06-05 2023-10-17 Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca Treatment of mitochondrial diseases

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856776A (en) * 1969-10-10 1974-12-24 Anvar Derivatives of cyclo adenosine-3 -,5 -phosphoric acid and their preparation
US3991045A (en) * 1973-05-30 1976-11-09 Asahi Kasei Kogyo Kabushiki Kaisha N4 -acylarabinonucleosides
US4208406A (en) * 1976-07-15 1980-06-17 Georges Cehovic Composition for the treatment and prevention of skin, eye and mucosal inflammation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA835941A (en) * 1970-03-03 L. Ruskin Simon Synergistic effect of adenylic nucleotides in digitalis therapy
JPS497414A (enExample) * 1972-05-24 1974-01-23
FR2536278A1 (fr) * 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
EP0151189B1 (en) * 1983-07-20 1990-01-31 Teijin Limited Antineoplastic agent
FR2556727B1 (fr) * 1983-12-19 1990-01-19 Biostabilex Labo Pharma Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation
US4785553A (en) * 1987-07-07 1988-11-22 Miller Brewing Company Multilane oven

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856776A (en) * 1969-10-10 1974-12-24 Anvar Derivatives of cyclo adenosine-3 -,5 -phosphoric acid and their preparation
US3991045A (en) * 1973-05-30 1976-11-09 Asahi Kasei Kogyo Kabushiki Kaisha N4 -acylarabinonucleosides
US4208406A (en) * 1976-07-15 1980-06-17 Georges Cehovic Composition for the treatment and prevention of skin, eye and mucosal inflammation

Also Published As

Publication number Publication date
WO1989010129A1 (en) 1989-11-02
IN169469B (enExample) 1991-10-19
RU2115410C1 (ru) 1998-07-20
DK256290D0 (da) 1990-10-24
AU3571389A (en) 1989-11-24
JPH0635389B2 (ja) 1994-05-11
DE68910973D1 (de) 1994-01-05
DK176007B1 (da) 2005-11-21
ZA892928B (en) 1991-01-30
DK256290A (da) 1990-12-21
FI905236A0 (fi) 1990-10-24
CA1336264C (en) 1995-07-11
EP0420862A4 (en) 1991-02-18
FI905236A7 (fi) 1990-10-24
EP0420862B1 (en) 1993-11-24
JPH03502694A (ja) 1991-06-20
DE68910973T2 (de) 1994-03-17
HK1005703A1 (en) 1999-01-22
EP0420862A1 (en) 1991-04-10
MX171542B (es) 1993-11-04

Similar Documents

Publication Publication Date Title
US5246708A (en) Methods for promoting wound healing with deoxyribonucleosides
EP0420862B1 (en) Pharmaceutical composition containing deoxyribonucleosides for wound healing
HK1005703B (en) Pharmaceutical composition containing deoxyribonucleosides for wound healing
AU610127B2 (en) Topical use of igf-ii for wound healing
CA2106073C (en) Composition for promoting tissue repair and regeneration
US4871752A (en) Use of aryloxycarboxylic acid derivatives against dermatological diseases
EP0173990A2 (en) External pharmaceutical composition
JPH01121300A (ja) 乳汁に由来するポリペプチド成長因子
EP0682521A1 (en) Method of treating damaged mucosal and epithelial tissues with misoprostol
WO2002094256A1 (en) Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
JPH11504899A (ja) 獣医学および医学用途用化合物
UA76415C2 (uk) Застосування похідних бігуаніду для отримання лікарського препарату з ефектом загоєння ран
BG64743B1 (bg) Използване на смес от диол и алфа-хидроксикиселина за лечение на хиперкератозни кожни заболявания
JP4252444B2 (ja) 傷の治療および再上皮形成のための糖蛋白質の使用
RU2202362C2 (ru) Композиция для местного применения, содержащая фактор роста эпидермиса человека
JPS58131962A (ja) 新規アミノ酸誘導体の製法
AU624222B2 (en) Compositions containing thymopentin for topical treatment of skin disorders
US6919320B1 (en) Pharmaceutical compositions containing deoxyribonucleosides for wound healing
CN114831939B (zh) 一种醋酸曲安奈德组合物喷雾剂及其制备方法
EP1009345A1 (en) Skin aging and wound treatment using cell migration agents
US5994399A (en) Method of regenerating collagen-containing tissues with misoprostol
RU2115424C1 (ru) Средство и способ стимуляции репаративной регенерации
EP2089050A2 (en) Il- 17b for use in wound healing
CN1579539A (zh) 胸腺素β15促进伤口愈合及血管生成
JPS6317825A (ja) 創傷治癒促進剤